Eloxx Pharmaceuticals, Inc. - ELOX
Detailed investor-level table based on 13F positions.
Early Q4 2023 data: only 2 institutional holders reported so far. The full shareholder list will grow as more funds file with the SEC.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | New | 275,000 | 1,322 | 0.02% | — | 1 | +275,000 | New | Q3 2023 | Nov 14, 2023 |
| MENORA MIVTACHIM HOLDINGS LTD. | History | No change | 52,355 | 251 | 0.0% | 0.0% | 2 | 0 | 0.0% | Q3 2023 | Nov 14, 2023 |
| Altshuler Shaham Ltd | History | No change | 25,123 | 120 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q3 2023 | Nov 13, 2023 |
| VANGUARD GROUP INC | History | Added to | 20,786 | 99 | 0.0% | 0.0% | 4 | +100 | 0.48% | Q3 2023 | Dec 18, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Reduced | 19,588 | 93 | 0.0% | 0.0% | 5 | -671 | -3.31% | Q3 2023 | Nov 13, 2023 |
| Tower Research Capital LLC (TRC) | History | Reduced | 1,830 | 8 | 0.0% | 0.0% | 6 | -649 | -26.18% | Q3 2023 | Nov 14, 2023 |
| WELLS FARGO & COMPANY/MN | History | Added to | 1,172 | 5 | 0.0% | 0.0% | 7 | +4 | 0.34% | Q3 2023 | Nov 13, 2023 |
| ROYAL BANK OF CANADA | History | Reduced | 526 | 3 | 0.0% | 0.0% | 8 | -260 | -33.08% | Q3 2023 | Nov 14, 2023 |
| UBS Group AG | History | New | 291 | 1 | 0.0% | — | 9 | +291 | New | Q3 2023 | Nov 09, 2023 |
| JPMORGAN CHASE & CO | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q3 2023 | Nov 14, 2023 |
| MORGAN STANLEY | History | No change | 79 | 0 | — | — | — | 0 | 0.0% | Q3 2023 | Nov 15, 2023 |
| GROUP ONE TRADING, L.P. | History | No change | 4 | 0 | — | — | — | 0 | 0.0% | Q3 2023 | Nov 09, 2023 |